SCHEMBL18068014

SCHEMBL18068014

CC(C)c1cc(C(C)C)nc(N2CCC2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SORD Q00796 1/20 0.51
▸ CASP1 P29466 1/20 0.40
▸ CASP4 P49662 1/20 0.40
▸ CASP5 P51878 1/20 0.40
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ HRH4 Q9H3N8 3/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ HRH3 Q9Y5N1 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ HRH1 P35367 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12986250 0.89 KMT2A (0.44) SORDMEN1KMT2AHRH4ALDH1A1
SCHEMBL12986688 0.85 GBA1 (0.47) SORDCASP1CASP4CASP5MEN1
SCHEMBL26141044 0.84 HTT (0.42) SORDCASP1CASP4CASP5MEN1
SCHEMBL12141944 0.83 GBA1 (0.46) SORDMEN1KMT2AHTTRECQL
SCHEMBL26704678 0.83 SORD (0.40) SORDCASP1CASP4CASP5MEN1
SCHEMBL19111287 0.82 KMT2A (0.53) SORDKMT2AHTTHRH4ALDH1A1
SCHEMBL26141097 0.77 SORD (0.47) SORDKDM4E
SCHEMBL21076626 0.74 CHRM3 (0.37) SORDHRH4HRH3CHRM3PDE4A
SCHEMBL12990426 0.73 SORD (0.47) SORDMEN1KMT2AHRH4ALDH1A1
SCHEMBL12986289 0.73 CASP1 (0.47) SORDCASP1CASP4CASP5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10179782-B2 Substituted sulfonamide compounds GENENTECH, INC. (US) 2019-01-15 — — US disclosed
US-20160264567-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GENENTECH, INC. (US) 2016-09-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10179782-B2 Substituted sulfonamide compounds TRPA1, TRPV1, TRPV5 SORD 1498/4885CASP1 1088/4885CASP4 1876/4885
US-20160264567-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS TRPA1, TRPV1, TRPV5 SORD 1498/4885CASP1 1088/4885CASP4 1876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback